Unresectable Malignant Solid Tumors

• CLINICAL_TRIALS trial_result · 2025-07-01
  Clinical Trial Update: Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study [Phase 2]

  Phase 2 BeGIN study results evaluate the glutaminase inhibitor telaglenastat hydrochloride in advanced and metastatic malignant solid tumors…